Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Taurine and Improved Diastolic Function

Doses used in studies

mg/day: 500–6,000 (median 3,250, IQR 500–6,000) — 1 study

Time to effect

Median: 2 weeks · IQR 2 weeks–2 weeks · Range 2 weeks–2 weeks — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
No significant safety concerns were reported.
from: Effect of taurine administration on symptoms, severity, or clinical outcome of dilated car
serious adverse eventsReportedSerious adverse event
No significant safety concerns were reported.
from: Effect of taurine administration on symptoms, severity, or clinical outcome of dilated car

1 of 1 paper

Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review.
- 2022-07-07
- Systematic Review · n = 250
- Wellcome open research 7
- - Kathryn A McGurk
  - Melpomeni Kasapi
  - James S Ware
- PubMed: 35855073
- DOI: 10.12688/wellcomeopenres.17505.3
6 Insights on
- Improved Diastolic Function
- High evidence
- Clinical
improvements in diastolic and systolic function, exercise capacity, and haemodynamic parameters were described
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
500 mg to 6 g per day